Literature DB >> 20592430

Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia.

Delphine Schoder1, Didier Hannequin, Olivier Martinaud, Gaëlle Opolczynski, Lucie Guyant-Maréchal, Isabelle Le Ber, Dominique Campion.   

Abstract

BACKGROUND: Familial co-occurrence of frontotemporal dementia and schizophrenia has never been investigated. AIMS: To test the hypothesis that frontotemporal dementia and schizophrenia might have a common aetiology in some families in which both syndromes coexist (mixed families).
METHOD: The morbid risk for schizophrenia, calculated in first-degree relatives of 100 frontotemporal dementia probands, was compared with that calculated in first-degree relatives of 100 Alzheimer's disease probands. In mixed families, sequencing analysis of known frontotemporal dementia genes and detailed phenotype characterisation of individuals with frontotemporal dementia and schizophrenia were performed.
RESULTS: The morbid risk for schizophrenia was significantly higher in relatives of frontotemporal dementia probands (1.35, s.e. = 0.45) than in relatives of Alzheimer's disease probands (0.32, s.e. = 0.22). Ten mixed families were characterised. In three of them a frontotemporal dementia causal mutation was identified that was present in individuals with schizophrenia. Several specific clinical features were noted in people with schizophrenia and frontotemporal dementia in mixed families.
CONCLUSIONS: Co-occurrence of schizophrenia and frontotemporal dementia could indicate, in some families, a common aetiology for both conditions.

Entities:  

Mesh:

Year:  2010        PMID: 20592430     DOI: 10.1192/bjp.bp.109.068981

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

Review 1.  Psychotic symptoms in frontotemporal dementia.

Authors:  Devin Hall; Elizabeth C Finger
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

2.  Saitohin polymorphism and executive dysfunction in schizophrenia.

Authors:  Marta Bosia; Mariachiara Buonocore; Carmelo Guglielmino; Adele Pirovano; Cristina Lorenzi; Alessandra Marcone; Placido Bramanti; Stefano F Cappa; Eugenio Aguglia; Enrico Smeraldi; Roberto Cavallaro
Journal:  Neurol Sci       Date:  2011-12-21       Impact factor: 3.307

Review 3.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

4.  C9ORF72 repeat expansions not detected in a group of patients with schizophrenia.

Authors:  Edward D Huey; Peter L Nagy; Laura Rodriguez-Murillo; Masood Manoochehri; Jill Goldman; Jeffrey Lieberman; Maria Karayiorgou; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2012-10-01       Impact factor: 4.673

Review 5.  Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness.

Authors:  Nicholas J Bradshaw; Carsten Korth
Journal:  Mol Psychiatry       Date:  2018-08-08       Impact factor: 15.992

6.  Structural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis.

Authors:  Bayanne Olabi; Ian Ellison-Wright; Ed Bullmore; Stephen M Lawrie
Journal:  BMC Psychiatry       Date:  2012-08-07       Impact factor: 3.630

7.  Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.

Authors:  Daniela Galimberti; Bernardo Dell'Osso; Chiara Fenoglio; Chiara Villa; Francesca Cortini; Maria Serpente; Sarah Kittel-Schneider; Johannes Weigl; Maria Neuner; Juliane Volkert; C Leonhard; David G Olmes; Juliane Kopf; Claudia Cantoni; Elisa Ridolfi; Carlotta Palazzo; Laura Ghezzi; Nereo Bresolin; A C Altamura; Elio Scarpini; Andreas Reif
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

8.  The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis.

Authors:  Costa Vakalopoulos
Journal:  Front Pharmacol       Date:  2014-12-15       Impact factor: 5.810

Review 9.  Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders.

Authors:  Roberta Zanardini; Miriam Ciani; Luisa Benussi; Roberta Ghidoni
Journal:  Front Aging Neurosci       Date:  2016-02-01       Impact factor: 5.750

10.  Does Schizophrenia in Offspring Increase the Risk of Developing Alzheimer's Dementia.

Authors:  Christopher Rohde; Esben Agerbo; Philip Rising Nielsen
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.